New heat treatment and AI could revolutionize cervical cancer prevention

NCT ID NCT07461818

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study in El Salvador tests a new thermal ablation device (IRIS™) to treat cervical precancer and an AI algorithm to help decide who needs treatment. About 5,000 HPV-positive women aged 30-49 will receive the treatment and be followed for one year to see if the precancer is cured. The goal is to make screening and treatment faster and more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
IRIS™ Thermal Ablation Device
What this could lead to
If successful, this could provide a more effective and efficient way to treat cervical precancer and triage HPV-positive women, potentially reducing cervical cancer rates.
What could go wrong
This is a single-country study with no control group, so results may not apply elsewhere. The AI triage algorithm is still being tested and may not be accurate enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Basic Health International

    RECRUITING

    San Salvador, San Salvador Department, El Salvador

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.